The main options available for the company are: To continue to Ignore bioresorbables, focusing on well established competences Metallic implants ; 2.
At the first visit on the six day after onset, the X - ray was normal. On the same day, MRI findings was osteomyelitis in the middle phalanx. However, the serum inflammatory response was negative. Serum rheumatic response was also negative, but antinuclear antibody was positive at times. On the 12th day after onset of disease, the vicinity of the epiphyseal line of the middle phalanx became erosive.
At this point, from literature search and pediatric consultation, we got a diagnosis of Microgeodic disease. The antibiotic was discontinued. Pain was relieved 2. At 4 weeks after onset, the middle phalanx fractured and fixed with the splint.
Bone fusion was somewhat late. There was no deformation healing, but the epiphyseal line of middle phalanx and distal phalanx closed. At 7 months after onset, the difference in bone length between bilateral middle phalanges was 2 mm.
The finger healed without dysfunction. Redness and swelling of fingers and toes like frostbite. It is accompanied by mild pain and itching. Predilection age is elementary school age 6 - 12 years old. It is mainly in the middle phalanx. A bone resorption image is recognized in the X-ray image. The cause is unknown, it is thought to be a transient bone circulation disorder.
Prognosis is usually good, it will heal spontaneously in about 6 months.
In this case, owing to attaching a diagnosis at a relatively early stage, appropriate treatment could be done. Microgeodic disease was reported 24 papers in PubMed. Since the arterial arch of the hand is predominant on the ulnar side, it seems that this disease is many in the index finger.
Oberg-Manske-Tonkin [OMT]-classificationbut none of these describe involvement proximal from the wrist other than radio-ulnar synostosis. One case of longitudinal cleavage of the upper extremity has been described in the literature.
Materials and methods An otherwise healthy 8-month-old infant presented with congenital split right forearm. Results Starting from the elbow joint, the forearm is divided into a superior radial forearm with a thumb and an index finger and an inferior ulnar forearm with two fingers.
X-rays showed a radius and two metacarpals in the radial forearm and a hypoplastic ulna and a single metacarpal supporting two digits in the shorter ulnar forearm.
The elbow joint of the radial part had an active and passive extension lag of 60 and 50 degrees, respectively, and an active and passive flexion of and degrees, respectively. An ulnohumeral synostosis was present and the ulnar forearm showed no motion. Conclusions This is the first reported case of congenital forearm.
A possible suggested ethiologic theory would be an error of limb bud specification in the 4th or 5th week of gestation. It has been suggested that the timing of an error in limb bud specification would determine the extent of duplication.Managing Technology: Synthes' Case Introduction Synthes is a leader maker and distributor of “internal fixation devices” and has to make a choice about a new technology (Bioresorbable implants).
The main options available for the company are: 1. Internal fixation devices in the past had been made of stainless steel or titanium, but with problems resulting from those permanent devices, an innovative approach is being considered.
Bioresorbable implants are a possible replacement to. RapidSorb Resorbable Fixation System Surgical Technique DePuy Synthes 1 INTRODUCTION Product Features and Benefits 2 Indications and Contraindications 3.
M&M Custom Research Services provides clients with the information on their business scenario required to stay ahead of competition in today's fast paced business environment. Managing Technology: Synthes' Case Introduction Synthes is a leader maker and distributor of “internal fixation devices” and has to make a choice about a new technology (Bioresorbable implants).
Synthes is a leader maker and distributor of “internal fixation devices” and has to make a choice about a new technology (Bioresorbable implants). The main options available for the company are: 1.